|
|
|
Insider
Information: |
Huff James Warren |
Relationship: |
Chief Executive Office... |
City: |
Irving |
State: |
TX |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
0 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
Percentage
Gain/Loss : |
0.0%
|
98.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Reata Pharmaceuticals Inc |
RETA |
Chief Executive Office... |
2023-09-26 |
0 |
2023-09-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RETA |
Reata Pharmaceuticals Inc |
Chief Executive Officer |
|
2023-09-26 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,398) |
0 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Executive Officer |
|
2023-09-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(122,480) |
0 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Executive Officer |
|
2023-07-06 |
4 |
A |
$0.00 |
$0 |
D/D |
84,220 |
122,480 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Executive Officer |
|
2023-03-02 |
4 |
S |
$81.49 |
$6,409,473 |
D/D |
(75,000) |
36,158 |
0 |
% |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Executive Officer |
|
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
111,158 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Executive Officer |
|
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
47,025 |
47,025 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Executive Officer |
|
2020-11-10 |
4 |
AS |
$175.00 |
$11,369,756 |
D/D |
(64,970) |
0 |
0 |
% |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Executive Officer |
|
2020-11-09 |
4 |
AS |
$175.06 |
$2,921,291 |
D/D |
(16,687) |
64,970 |
0 |
% |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Executive Officer |
|
2019-09-27 |
4 |
S |
$86.61 |
$5,456,115 |
D/D |
(63,000) |
94,157 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Executive Officer |
|
2019-09-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
19,500 |
157,157 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
Chief Executive Officer |
|
2019-09-23 |
4 |
GA |
$0.00 |
$0 |
I/I |
12,500 |
12,500 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
See Remarks |
|
2016-06-01 |
4 |
A |
$0.00 |
$0 |
I/I |
3,166 |
3,166 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
See Remarks |
|
2016-06-01 |
4 |
B |
$11.00 |
$1,254,000 |
D/D |
114,000 |
176,657 |
2.81 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
See Remarks |
|
2016-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
62,657 |
62,657 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|